crypto at Top

CMB International: Upgraded the target price of WuXi Bio to HK$ 22.88, optimistic about the company's valuation and performance repair. CMB International published a report, predicting that the US Biosafety Act will fail with high probability, which will help WuXi Bio to achieve continuous performance growth in a relatively stable business environment. With the recovery of global biomedical financing, we are optimistic about the company's valuation and performance repair. According to the report, the NDAA in FY 2025 does not include the Biosafety Act, and the legislation of the Biosafety Act failed with high probability. On December 7, the US Senate and the House Armed Services Committee announced the National Defense Authorization Act (NDAA) for fiscal year 2025, which was finally negotiated by the committees of the two houses. The Biosafety Act was not included in the amendment of NDAA in FY 2025, which means that the Biosafety Act failed to pass the legislative path of joining NDAA. The Biosafety Act can still promote separate legislation, but considering that the window of the current US Congress session is less than two weeks, the Bank believes that the success rate of separate legislation is extremely low. CMB International maintained the "Buy" rating of Yaoming Bio, and its target price rose from HK$ 13.58 to HK$ 22.88. It is estimated that the company's revenue will increase by 7.1%/12.4%/ 13.9% from 2024 to 2026, and its adjusted net profit will increase by 0.8%/11.1%/13.4% respectively.Market news: Russian troops advance to strategic cities in eastern Ukraine.The winning bid rate of China's 2-year treasury bonds was 1.06%, which was 31 basis points lower than last month. The Ministry of Finance of China issued treasury bonds today, and the weighted average winning bid rate of 2-year varieties was 1.06%. The data shows that the bid-winning interest rate is about 31 basis points lower than that when the national debt of the same term was issued in November, the lowest since Bloomberg recorded it in 2004.

Sora concept stocks strengthened, Huace Film and Television rose by more than 10%, Sora concept stocks strengthened, Huace Film and Television rose by more than 10%, Fengyuzhu and Tianyu Entertainment both went up, and Borui Communication, Jincai Internet, Yuanlongyatu and Huayang Lianzhong followed suit.Tin Venture Capital and other companies have invested 300 million yuan in establishing low-altitude economic equity investment partnership. According to Tianyancha App, recently, Wuxi Liangxi Science and Technology City Xichuang Low-altitude economic equity investment partnership (limited partnership) was established. The executive partner is Wuxi Guolian Industrial Investment Private Equity Fund Management Co., Ltd., with a capital contribution of 300 million yuan. Its business scope includes investment activities and venture capital with its own funds, and it is invested by Wuxi Innovation Investment Group Co., Ltd., Wuxi Xiangyun Investment Co., Ltd. and Wuxi Liangxi Science and Technology City.Research shows that the French "online celebrity" economy will earn nearly 6.5 billion euros in 2024. A research report released in Paris recently shows that the French "online celebrity" economy will earn nearly 6.5 billion euros in 2024, accounting for 0.16% of the country's gross domestic product (GDP).

CMB International: Upgraded the target price of WuXi Bio to HK$ 22.88, optimistic about the company's valuation and performance repair. CMB International published a report, predicting that the US Biosafety Act will fail with high probability, which will help WuXi Bio to achieve continuous performance growth in a relatively stable business environment. With the recovery of global biomedical financing, we are optimistic about the company's valuation and performance repair. According to the report, the NDAA in FY 2025 does not include the Biosafety Act, and the legislation of the Biosafety Act failed with high probability. On December 7, the US Senate and the House Armed Services Committee announced the National Defense Authorization Act (NDAA) for fiscal year 2025, which was finally negotiated by the committees of the two houses. The Biosafety Act was not included in the amendment of NDAA in FY 2025, which means that the Biosafety Act failed to pass the legislative path of joining NDAA. The Biosafety Act can still promote separate legislation, but considering that the window of the current US Congress session is less than two weeks, the Bank believes that the success rate of separate legislation is extremely low. CMB International maintained the "Buy" rating of Yaoming Bio, and its target price rose from HK$ 13.58 to HK$ 22.88. It is estimated that the company's revenue will increase by 7.1%/12.4%/ 13.9% from 2024 to 2026, and its adjusted net profit will increase by 0.8%/11.1%/13.4% respectively.In the communication service sector, the daily limit of Bee Assistant was higher, and the communication service sector was higher. The daily limit of Xiangjiang and Bee Assistant in the city was higher. Three-dimensional communication and Beiwei Technology were previously closed, and Runze Technology rose by more than 10%. Century Hengtong, Halo New Network, Chaoxun Communication, Guangmai Technology and Runjian shares followed suit.EDI SUSIANTO, Executive Director of the Bank of Indonesia: The decline of the Indonesian rupiah was affected by global sentiment and the rise of the US dollar.